These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 4198304)

  • 1. The extrapyramidal neuroleptic syndrome: description and measurement.
    Elie R; Gagnon MA; Lamontagne Y; Tetreault L
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 3. Polygraphic studies of tardive dyskinesia and of the rabbit symdrome during different stages of sleep.
    Villeneuve A; Jus K; Jus A
    Biol Psychiatry; 1973 Jun; 6(3):259-74. PubMed ID: 4732255
    [No Abstract]   [Full Text] [Related]  

  • 4. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 5. The rabbit syndrome. A peculiar extrapyramidal reaction.
    Villeneuve A
    Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Paroxysmal extrapyramidal syndrome caused by taking neuroleptic drugs].
    Gurovich IIa; Fleĭs EP
    Klin Med (Mosk); 1969 Sep; 47(9):132-7. PubMed ID: 5397873
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
    Deniker P; Ginestet D
    Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
    [No Abstract]   [Full Text] [Related]  

  • 11. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
    Vatsek Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM; Tétreault L; Elie R
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S; Buddeberg C
    Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary neurologic manifestations of psychotropic therapeutics. Neurophysiological approach].
    Rigal J; Savelli A; Juillet P
    Ann Med Interne (Paris); 1972 May; 123(5):541-7. PubMed ID: 4263578
    [No Abstract]   [Full Text] [Related]  

  • 15. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
    Berchtold P; Hinssen M; Irmscher K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic facio-lingual dyskinesia in patients treated with neuroleptics].
    Gralewski Z
    Neurol Neurochir Pol; 1973; 7(3):393-8. PubMed ID: 4714195
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P; Robotti E; Nardini M
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract]   [Full Text] [Related]  

  • 18. The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal diseases.
    Faurbye A
    Compr Psychiatry; 1970 May; 11(3):205-25. PubMed ID: 4315299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A
    Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
    [No Abstract]   [Full Text] [Related]  

  • 20. [Somatic disorders during long-term drug treatment of schizophrenic patients].
    vom Brocke I
    Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.